Capstan Medical, founded in 2020, is developing a minimally invasive technology to treat mitral and tricuspid valve disease. The Santa Cruz company recently raised $31.4 million in a Series B fundraising round led by Palo Alto-based venture capital firm Eclipse. The funding will help with hiring in four key areas — software and controls engineering, mechanical engineering, clinical and operations.

